AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00827281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-cycloserine
Description: Single dosage prior to sessions 3, 4 \& 5
Study NCT00827281 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single dosage prior to sessions 3, 4 \& 5
Study NCT01189058 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: TMS can affect discrete functional ares of motor cortex offering non-invasive, painless mapping and modulation of motor systems. Inhibitory rTMS (1Hz)has been shown to safely lower motor cortex excitability in normal patients as well as adult and pediatric stroke patients. Dose is 20 minutes per day (1200 stimulations) x 10 days administered over the non-lesioned M1.
Study NCT01189058 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Description: CIMT uses gentle restraint of the fully functional upper extremity to promote functional gains in the affected upper extremity. CIMT is well established to be safe and is likely effective in children with hemiplegic cerebral palsy, many of whom have perinatal stroke as studied here. A custom-fitted, bivalved cast is applied and worn for >90% of waking hours for the 2 weeks of active treatment according to protocol with daily assessments for comfort.
Study NCT01264172 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCCP
Description: PCCP: an minimal-invasive surgery technique, in wich a special plate is pushed in position and fixed through 2 small approaches only (about 2 cm long)
Study NCT02570581 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Apple compote Alprazolam
Study NCT02570581 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Oxazepam
Study NCT02570581 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Apple compote Oxazepam
Study NCT02570581 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Donepezil
Study NCT01973647 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: Six weekly sessions of cognitive behavioral therapy for insomnia
Study NCT01264172 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: DHS
Description: Conventional surgical treatment of proximal femur fracture including one longer approach from lateral
Study NCT01264172 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Osteosynthesis with nails
Description: Osteosynthesis with nails is a minimal-invasive surgery technique for proximal femur fractures.
Study NCT01973647 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COPD Education
Description: Six weekly sessions of COPD education
Study NCT01973647 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Attention Control
Description: Six weekly sessions of non-sleep, non-COPD health education
Study NCT03947944 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SMILE using vector planning
Description: The treatments of astigmatism were planned using either the manifest refraction (manifest refraction group) or the vector planning method (vector planning group). The surgery was performed with standardized techniques with triple centration technique using the 500-KHz VisuMax system (Carl Zeiss Meditec AG, Jena, Germany). The superior cap depth was set as 120 µm, and the length of the side cut was set to 2 mm. Once the anterior (upper) and posterior (lower) planes of the lenticule were defined, the anterior and posterior interfaces were dissected using a microspatula with a blunt circular tip and extracted with microforceps. The integrity of the lenticule was assessed subsequently. The treatment plan for the vector planning group involved a combination of refractive astigmatism with 60 % emphasis and corneal astigmatism with 40 % emphasis.
Study NCT00340678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan
Description: Treatment with losartan began at 50 mg daily, with the dose increasing to 100 mg daily after 1 week if symptomatic hypotension did not develop.
Study NCT05070117 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: Study participants perform resistance/strength exercises 2-3 times per week for one hour, for one year.
Study NCT02845245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D printed plastic model prototype
Study NCT02845245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D CT scan
Study NCT00340678 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Treatment with placebo corresponding to each dose of losartan.
Study NCT02845245 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 3D CT scan
Study NCT02845245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plain film radiographs
Study NCT02845245 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Plain film radiographs
Study NCT02014896 — intervention group
Intervention type: OTHER
Intervention: Biomarker blood draw
Description: Comparison of gene expression profiles using RNA isolated from whole blood.
Study NCT01345578 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: human hepatocyte transplantation
Description: Transplantation of hepatocytes into the liver will be through the portal vein. The portal vein will be accessed transhepatically, by umbilical vein, or surgically by a peripheral mesenteric vein.~The subject will be evaluated de novo and if they are a candidate for orthotopic liver transplantation they will receive the transplant. Even if the subject receives the hepatocyte transplant and it does not work, they will be evaluated for orthotopic liver transplantation as if they never received the hepatocyte transplant.~If at 6 months we see an improvement in disease, we will recommend a re-transplantation with a goal of complete correction of disease and until the subject is no longer required to be a candidate for organ transplantation. Subjects will be re-evaluated every 6 months for re-transplantation. Subjects will remain on the waiting list for organ transplantation. Further radiation therapy will not be needed prior to re-transplantation.
Study NCT02570581 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Apple compote Donepezil
Study NCT02570581 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Clopidogrel
Study NCT01345578 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Preparative Radiation Therapy
Description: Just prior to the hepatocyte transplant, a portion of the right hepatic lobe comprising between 35-50% of the entire liver volume will be irradiated to a dose of 7.5-10 Gy in a single fraction using a linear accelerator-based stereotactic radiosurgery system with intensity-modulated radiation therapy planning (IMRT).
Study NCT00627510 — intervention group
Intervention type: OTHER
Intervention: Routine psychiatric inpatient treatment
Description: Routine psychiatric inpatient treatment. This is not an interventional study.
Study NCT04590352 — intervention group
Intervention type: PROCEDURE
Intervention: nasopharyngeal and throat swab
Description: diagnostic specimens via nasopharyngeal swab and throat swab were collected following the current standard operating procedures.
Study NCT00531050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol
Description: Single dose of indacaterol 300μg capsule via Concept 1 inhaler device at approximately the same time in the morning (i.e. between 8am and 9am).
Study NCT00531050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose indacaterol matching placebo via Concept 1 device
Study NCT00531050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol
Description: Single dose salmeterol 50μg via the Diskus dry powder inhaler (DPI) in part 1 of the study. Morning single inhalational dose and an evening single inhalation dose of salmeterol 50μg via the Diskus DPI in part 2 of the study.
Study NCT01601249 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Embryo selection based on polscope grading or morphology
Description: In the experimental arm embryo grading will be performed by polscope rather than conventional morphology, and the best embryo/s for transfer will be selected by this method.
Study NCT01601249 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Embryo selection based on polscope grading or morphology
Description: In the experimental arm embryo grading will be performed by polscope rather than conventional morphology, and the best embryo/s for transfer will be selected by this method.
Study NCT01842256 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg
Description: * 3 Tablets (telmisartan 80mg, amlodipine 5mg, atorvastatin 40mg each one),~* oral intake, once in a period~* over the period Ⅰ\&Ⅱ(crossover)
Study NCT04590352 — intervention group
Intervention type: PROCEDURE
Intervention: collection of mucosal lining fluid
Description: MLF will be collected via nasal absorption at the inclusion visit by study staff and four more time points by the parents or by the children themselves. Nasal absorption is performed by maneuvering a strip of synthetic absorptive matrices (SAM) into the lumen of the nostril, avoiding rubbing against the nasal mucosa. The outside of the nose is then pressed with a finger to cause apposition of the SAM against the mucosa.
Study NCT04590352 — intervention group
Intervention type: PROCEDURE
Intervention: blood collection via fingerprick
Description: Participants will be asked to wash their hands with soap and warm water. The procedure involves cleaning the ball of the fingertip with an alcohol swab, then using a sterile disposable lancet to pierce the skin (BD Microtainer Lancet or similar). The lancet is placed in a spring-loaded device, which propels the lancet a fixed distance (a few mm) into the skin when the trigger is pressed. Approximately 10-20 drops of blood (0.3 ml) will then be collected with a sterile capillary tube. The participant is given a cotton wool pad to mop up any extra blood, and an elastoplast-type bandage is placed over the finger if necessary. Fingerprick blood samples will only be collected from participants older than 6 months at 28-32 days after the first home visit (d0). Lancet length will be adjusted for age (2.0 mm for participants 8 years and older, 1.5 mm for participants older than 6 months and younger than 8 years).
Study NCT01842256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg
Description: * 3 Tablets (telmisartan 80mg, amlodipine 5mg, atorvastatin 40mg each one),~* oral intake, once in a period~* over the period Ⅰ\&Ⅱ(crossover)
Study NCT01842256 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: atorvastatin 40mg
Description: * 1 Tablet (atorvastatin 40mg),~* oral intake, once in a period~* over the period Ⅰ\&Ⅱ(crossover)
Study NCT01842256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: atorvastatin 40mg
Description: * 1 Tablet (atorvastatin 40mg),~* oral intake, once in a period~* over the period Ⅰ\&Ⅱ(crossover)
Study NCT02781051 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Print-based education
Description: All subjects will be given a copy of Exercise for Health: An Exercise Guide for Breast Cancer Survivors. Topics covered within the book include benefits of exercise in breast cancer survivors; recommendations on type, duration, frequency and intensity of exercise; goal-setting; and advice on overcoming barriers.
Study NCT02781051 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fitbit
Description: Subjects will be provided with a commercially available activity monitor (i.e., Fitbit) and instructed to wear the device daily.
Study NCT02781051 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Living counseling
Description: The Active Living counseling program consists of 12 weekly group educational sessions, facilitated by project interventionists. These sessions will involve discussion of topics related to increasing physical activity, including: identifying and overcoming barriers, setting goals, and time management.
Study NCT02781051 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Facility Access
Description: Subjects will have access to the exercise lab in the UT Southwestern Depression Center consisting of equipment for aerobic exercise (treadmills, stationary bikes, etc.).
Study NCT03637972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ventilated cigarettes only
Description: Participants given vouchers that are exchanged for ventilated cigarettes study cigarettes.
Study NCT03637972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unventilated cigarettes only
Description: Participants given vouchers that are exchanged for unventilated cigarettes study cigarettes.
Study NCT03637972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Access to Experimental Marketplace: Ventilated cigarettes + alternative nicotine delivery systems
Description: Participants given vouchers that are exchanged for ventilated cigarettes + alternative nicotine delivery systems cigarettes.
Study NCT03637972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Access to Experimental Marketplace: Unventilated cigarettes + ANDS
Description: Participants given vouchers that are exchanged for unventilated cigarettes + ANDS.
Study NCT03263442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thiamine
Description: 200 mg IV three times daily for seven days
Study NCT03263442 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Normal saline IV three times daily for seven days
Study NCT01464385 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Nutritional Beverage
Description: Nutritional Beverage Oral 237mL
Study NCT01464385 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional Beverage
Description: Nutritional Beverage Oral 237 mL
Study NCT01464385 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional Beverage
Description: Nutritional Beverage Oral 237mL
Study NCT03917108 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: retraction cord
Description: retraction cord ( Ultra dent sizes #0, #00, #000 ) is placed in the gingival sulcus using blunt instrument and using cotton roll isolation.
Study NCT03917108 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: subgingival clamp
Description: subgingival clamp (KSK clamps W8A, #44, #42, #43) or (Brinker clamps B5, B6) is placed to retract the gingiva with rubber dam isolation
Study NCT03045081 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PainTracker Self-Manager
Description: Interactive web-based educational and assessment program supported by a nurse care manager
Study NCT05060159 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hemofiltration
Description: Postdilutional Hemofiltration
Study NCT00016146 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GPI-0100
Study NCT00016146 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MUC-2-Globo H-KLH conjugate vaccine
Study NCT02699554 — intervention group
Intervention type: PROCEDURE
Intervention: Single-event multilevel surgery
Study NCT03324854 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rives technique
Description: Open ventral hernia repair followed by the placement of the mesh.
Study NCT03324854 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rives technique
Description: Open ventral hernia repair followed by the placement of the mesh.
Study NCT03324854 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Drainage
Description: Placement of active-close drainage in surgical site.
Study NCT03324854 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Drainage
Description: Placement of active-close drainage in surgical site.
Study NCT03324854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prophylactic
Description: Prophylactic antibiotic 1gm of cefalotin was administered 30 minutes before the incisión.
Study NCT03324854 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prophylactic
Description: Prophylactic antibiotic 1gm of cefalotin was administered 30 minutes before the incisión.
Study NCT01484873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exenatide
Description: Treatment with exenatide 5 mcg twice daily for 4 weeks, then 10 mcg twice daily for 46 weeks.
Study NCT03012412 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Program for Infertility
Description: The Mindfulness Based Program for Infertility is a manualized group psychological intervention derived from contextual or 3rd wave cognitive-behavioral therapies intended to develop mindfulness and acceptance skills, as well as to promote perceptions of self-efficacy to deal with the demands of an infertility diagnosis and medical treatment. It comprises 10 weekly sessions of approximately 2hr each, run in small groups (ranging from 10 to 13 participants).
Study NCT03416257 — intervention group
Intervention type: OTHER
Intervention: No intervention
Study NCT03356951 — intervention group
Intervention type: PROCEDURE
Intervention: TAR through anterior approach and subtalar fusion
Description: Simultaneous total ankle replacement through anterior approach and subtalar fusion
Study NCT03356951 — intervention group
Intervention type: PROCEDURE
Intervention: TAR through lateral approach and subtalar fusion
Description: Simultaneous total ankle replacement through lateral approach and subtalar fusion
Study NCT01549392 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DECT
Description: DECT at tumor progression and 3 months later
Study NCT01549392 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MR spectroscopy
Description: MR spectroscopy at tumor progression and 3 months later
Study NCT05615571 — intervention group
Intervention type: GENETIC
Intervention: Establishment of mitochondrial markers
Description: Establishment of mitochondrial markers from fibroblasts in culture, obtained from a skin biopsy. Establishment of yeast models to show biochemical mitochondrial alterations: introduction of missense variants in the pantothenate kinase yeast gene Cab1 whose deletion is lethal, followed by growth of mutant strains on fermentation and respiratory media.
Study NCT05615571 — intervention group
Intervention type: GENETIC
Intervention: Sequencing tests
Description: sequencing tests of a panel of 22 genes (9 already known and 13 new genes) using a dedicated custom capture and a medium throughput sequencing protocol.
Study NCT01647282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: locally-applied minocycline HCl (1 mg)
Study NCT02570581 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Apple compote Clopidogrel
Study NCT02822378 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dried Plum
Description: Participants randomized to the 50g dried plum group will consume 6 dried plums per day for the duration of the 52 week intervention. Participants randomized to the 100g dried plum group will consume 12 dried plums per day for the duration of the 52 week intervention.
Study NCT02822378 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium supplement
Description: All participants will consume calcium supplements for the duration of baseline and intervention.
Study NCT01647282 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: scaling and root planing (Sc/RP)
Study NCT01647282 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: scaling and root planing (Sc/RP)
Study NCT02570581 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple compote Ramipril
Study NCT03009565 — intervention group
Intervention type: OTHER
Intervention: coronary artery disease
Study NCT01179945 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: benzoate containing test drinks
Description: Subjects will consume 500ml of water with 0.5 grams of sodium benzoate, followed by a solution of 75g sugar in 500ml water with 0.5 grams sodium benzoate 3 hours later.~Each solution will be consumed over 5 minutes.
Study NCT01179945 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: non sodium benzoate containing test drinks
Description: Subjects will consume 500ml of water followed by a solution of 75g sugar in 500ml water 3 hours later.~Each solution will be consumed over 5 minutes.
Study NCT02105428 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Training
Description: A progressive increase in duration, frequency and intensity so the last 8 weeks of exercise are performed for 60 min, 5 days per week and at 80% of aerobic capacity. The duration includes a 5 minute warm up and 5 minute cool down. All exercise will be performed on a stationary bicycle (i.e., cycle ergometer).
Study NCT04256785 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: VSL#3
Description: sachets containing probiotic
Study NCT04256785 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: sachets containing placebo
Study NCT02570581 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Apple compote Ramipril
Study NCT00826020 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omegaven™
Description: 10% Omegaven™, 50 or 100 mL bottle; 1gram/kg/day and is infused over 12-24 hours.